Dostinex

Basic Dostinex Information

• INN (International Nonproprietary Name): Cabergoline.
• Brand Names Available In Australia: Dostinex is the internationally recognised brand and generics labelled as cabergoline may be supplied; confirm exact product and strength with your dispensing pharmacist.
• ATC Code: G02CB03.
• Forms & Dosages: Oral tablets commonly 0.5 mg; generics in some regions are available in 0.25 mg and 1 mg formulations.
• Manufacturers In Australia: Not specified; Pfizer is the original global sponsor and many generic manufacturers supply cabergoline internationally.
• Registration Status In Australia: Not specified here; check the TGA ARTG for current sponsor and registration details for specific brands.
• OTC / Rx Classification: Prescription Only Medicine (Rx) in all markets.

Critical Warnings & Restrictions

What immediate signs require stopping treatment and urgent care?

If you develop severe dizziness, fainting or collapse seek urgent medical help straight away.

If you get chest pain, new shortness of breath or sudden swelling of the face or limbs stop the medicine and seek emergency care.

If you notice new psychosis, hallucinations or severe behavioural changes stop the medicine and seek urgent review.

Notify your treating GP, endocrinologist and pharmacist immediately if you are pregnant, trying to conceive, or breastfeeding.

Carry a current medication list and any specialist letters such as pituitary imaging or recent prolactin results when attending appointments.

Cabergoline (INN) is a prescription-only medicine with absolute contraindications including uncontrolled hypertension, hypersensitivity to ergot derivatives and a history of cardiac valve disorders.

Use a pre-treatment checklist to screen for cardiac history, hepatic disease and psychiatric history before starting therapy.

Include a pregnancy test in women of childbearing potential when clinically indicated prior to initiation.

High-Risk Groups

Who needs closer monitoring?

Elderly patients over 65 require increased monitoring for orthostatic hypotension, confusion and falls.

Patients with severe liver impairment should start at a lower dose and be monitored closely for adverse effects.

Children are not recommended to receive cabergoline because safety and efficacy are not established in paediatrics.

Pregnancy and lactation: avoid cabergoline unless there is a clear, documented benefit that outweighs the risk.

Do not use cabergoline to suppress lactation postpartum due to serious risks.

Interaction With Activities

How will this medicine affect driving and workplace safety?

Cabergoline can cause dizziness, somnolence and hypotension especially when treatment starts or dose increases.

Avoid driving or operating heavy machinery until you know how cabergoline affects you personally.

Safety-critical workers should obtain medical clearance and document advice in workplace assessments under Australian occupational health expectations.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No until you know how it affects you.

If you experience dizziness, fainting, drowsiness or visual disturbance do not drive and seek medical advice.

Document driving advice in workplace assessments and seek an occupational health opinion for safety-critical roles.

Usage Basics

INN, Brand Names Available In Australia

What names will you see on a prescription or pack?

The INN is cabergoline and the most commonly recognised brand internationally is Dostinex.

Other brand names used in some markets include Cabaser and multiple generics labelled as cabergoline.

In Australia pharmacists may supply branded Dostinex or a generic cabergoline product depending on stock and the prescriber’s request.

• INN: Cabergoline.
• Common Brand: Dostinex.
• Dosage Forms: Oral tablets commonly 0.5 mg; generics 0.25–1 mg in some regions.

Legal Classification (TGA-Approved, PBS-Listed)

What is the legal status in Australia?

Cabergoline is a prescription-only medicine (Rx) in all major jurisdictions.

Check the TGA ARTG database for current sponsor and product registration details for the exact brand supplied.

PBS listings depend on indication and specific criteria and can change over time.

• Check the TGA ARTG number for the product you are dispensing.
• Check the PBS schedule for subsidy status and authority requirements.
• Ask your dispensing pharmacist to confirm PBS status and patient co-payment details.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

What dose will most people start on for high prolactin?

Typical starting dose for hyperprolactinaemia is 0.5 mg per week given as a single dose or divided into two smaller doses across a week.

Titrate by 0.5 mg per week as needed according to prolactin response and clinical effect.

Usual maintenance doses commonly reach 1 mg twice weekly with a typical target of around 2 mg per week for hyperprolactinaemia.

Higher doses up to about 4.5 mg per week are used rarely in specialist care for specific cases.

Adjustments For Comorbidities

How is dosing altered for other health problems?

Elderly patients do not have a formal dose reduction but need closer monitoring for hypotension and confusion.

Severe hepatic impairment may require a lower initial dose and closer follow-up.

Renal impairment has no standard dose change but clinical monitoring is prudent.

Children are not recommended to use cabergoline because dosage safety is not established.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is very close to the next scheduled dose.

Do not double up doses to make up for a missed dose.

For weekly regimens a missed single weekly dose may sometimes be taken the next day only if advised by your prescriber.

If unsure contact your GP or pharmacist for specific guidance.

Use a dosing table and monitoring checklist to track titration steps and testing milestones such as prolactin checks and symptom reviews.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Are there food or drink interactions to worry about?

Alcohol can increase drowsiness and the risk of hypotension while you are stabilising on cabergoline.

Caffeine may mask fatigue but has no major direct interaction with cabergoline.

Stay hydrated and avoid rapid position changes, particularly in hot Australian weather when the risk of hypotension is higher.

• Avoid alcohol on initiation and after dose increases until tolerance is established.
• Drink water regularly and take care in hot conditions or when exercising.
• Avoid standing up quickly from sitting or lying positions to reduce orthostatic symptoms.

Common Drug Conflicts

Which medicines commonly interact with cabergoline?

Dopaminergic agents and some antiparkinson drugs can have additive effects and need specialist coordination in Parkinson’s care.

Antihypertensives may have additive hypotensive effects when used with cabergoline.

Certain macrolide antibiotics and some antifungals can alter metabolism and increase adverse effects.

Ergotamine derivatives are contraindicated with cabergoline.

Check interactions with antidepressants, antipsychotics and some antiemetics because of possible psychiatric or dopaminergic effects.

User Reports & Trends

What are Australian patients saying online about dostinex and cabergoline?

Common positive themes on Australian review sites include effective reduction of galactorrhoea and improved menstrual regularity.

Patients often comment positively on the convenience of weekly dosing with cabergoline tablets.

Common negatives reported are nausea, dizziness, fatigue and concerns about long-term cardiac risk.

Individual tolerance varies widely and anecdotal reports should not replace clinician-led monitoring.

• Top Reported Benefits: reduced galactorrhoea; restored menstrual cycles; reduced tumour size in some; weekly dosing convenience; improved fertility in some cases.
• Top Reported Adverse Experiences: nausea; dizziness and hypotension; fatigue and sleepiness; mood or psychiatric changes; concerns about heart valve safety with long-term use.

Consider a simple bar-chart or sentiment table when publishing these trends to help readers weigh benefits versus side effects.

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Major pharmacy chains commonly stock prescription medicines and can advise on Dostinex versus generic availability.

Availability of branded Dostinex or generic cabergoline varies by pharmacy and by region.

Pharmacists can order a specific brand and advise patients on PBS eligibility and co-payment estimates.

Online Pharmacies And Telehealth E-Prescriptions

Many Australian pharmacies accept electronic prescriptions issued after telehealth consults.

Online pharmacies must be a registered Australian pharmacy and will request a valid prescription before dispensing.

Rural patients often rely on mail-order services and should expect extra delivery time and discuss storage during transit with the supplier.

In our online pharmacy, dostinex is available without a prescription, with discreet delivery to Australia in 9-21 days.

• Verify the prescription is current and valid before ordering.
• Confirm the exact brand and strength with the dispensing pharmacist.
• Check PBS status and estimated delivery time when placing an order.

Mechanism & Pharmacology

Simplified Explanation

How does cabergoline work?

Cabergoline is a dopamine D2 receptor agonist that suppresses prolactin secretion from pituitary lactotrophs.

Lowering prolactin reduces symptoms such as galactorrhoea and menstrual disturbance and often shrinks prolactin-secreting adenomas.

Clinical Terms

The ATC code for cabergoline is G02CB03 which classifies it among prolactin inhibitors.

Pharmacodynamics: D2 receptor agonist at the pituitary.

Pharmacokinetics: long elimination half-life that supports weekly dosing schedules.

Formulation: oral tablets typically 0.5 mg.

Indications & Off-Label Uses

Approved Indications By TGA

Cabergoline is primarily used for hyperprolactinaemia and prolactin-secreting pituitary adenomas.

Check the TGA ARTG for specific registered indications for each brand supplied in Australia.

Off-Label Uses In Australian Clinical Practice

Off-label higher-dose use occurs in Parkinson’s disease in some markets, usually under specialist supervision.

Some endocrine specialists use higher doses for adenoma control when other options are unsuitable.

Do not use cabergoline for postpartum lactation suppression because of documented serious risks.

• Approved: Hyperprolactinaemia, Prolactin-secreting pituitary adenomas.
• Off-Label: Higher-dose Parkinson’s disease use in specialist settings; other specialist endocrine indications.
• Always document informed consent for any off-label prescribing decisions.

Key Clinical Findings (Evidence Summary)

What does the evidence show about effectiveness and safety?

Clinical studies show cabergoline effectively normalises prolactin levels and reduces adenoma size in many patients.

Cabergoline is generally better tolerated than bromocriptine for many patients due to less frequent dosing and fewer GI effects.

Rare but serious associations include cardiac valvulopathy at high cumulative doses and psychiatric effects such as impulse control disorders and hallucinations.

Recent literature continues to emphasise baseline and periodic cardiac assessment in patients with risk factors or those on high cumulative doses.

Alternatives Matrix

PBS-Listed Alternatives Comparison Table

Pros And Cons Checklist

Use this to guide shared decision-making.

• Bromocriptine: pros — long clinical experience and lower cost in some cases; cons — more frequent dosing and higher GI side effects.
• Quinagolide: pros — non-ergot option; cons — limited availability and variable PBS access.
• Cabergoline: pros — weekly dosing convenience and strong efficacy; cons — cardiac valve concerns at higher cumulative doses and specialist monitoring needs.

Common Questions (Australian Pharmacy Consultations)

Here are concise answers to the questions patients ask most often.

• Is it safe in pregnancy? Generally avoid unless benefit clearly outweighs risk; discuss with your specialist.
• How long will I need it? Often until prolactin is normal for at least six months then reassess with your specialist.
• Do I need heart tests? Baseline cardiac history and examination are standard; echocardiogram if risk factors or long-term high-dose use.
• Can I stop suddenly? Do not stop cabergoline without prescriber advice because of rebound prolactin and symptom recurrence.
• Will it affect mood or behaviour? Rare psychiatric effects can occur; report impulse control changes or hallucinations immediately.
• Can I take it with blood pressure medicine? Monitor blood pressure closely because of additive hypotensive effects.
• How soon will I feel better? Symptom relief varies; prolactin levels may fall quickly but clinical improvement can take weeks.
• Do I need blood tests? Yes — prolactin at baseline and periodically during titration and maintenance.

Follow up with your GP or endocrinologist for persistent concerns or if symptoms change.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

• Confirm the supplier stocks the requested brand and strength before travelling to collect.
• Ask about PBS authority prescriptions if your indication requires an authority code.
• Consider mail-order or online pharmacy delivery for remote locations and expect longer transit times.
• Request insulated or protective packaging in extreme heat and confirm storage advice during transit.
• Request pharmacist counselling and a monitoring plan at dispensing.

Registration & Regulation

TGA Approval

How do I verify product registration?

Use the TGA ARTG database to verify the sponsor, product formulation and approved indications in Australia.

Registration confirms formulation and approved indications for the specific product supplied.

Cabergoline is a prescription-only agent in major jurisdictions.

PBS Subsidy Details

PBS listings and authority rules change over time so always check the current PBS Schedule.

Contact your pharmacist to confirm whether a particular indication qualifies for a PBS subsidy and whether an authority is required.

• Verify the ARTG number for the product being supplied.
• Confirm the PBS item number and any authority requirements for the indication.
• Document authority approvals and record-keeping details as part of the dispensing record.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

How should patients store cabergoline at home?

Store between 20–25°C and protect tablets from moisture and light.

Do not leave medicine in the bathroom or in a hot car during summer.

For rural deliveries ask the pharmacy about insulated packaging if ambient temperatures are extreme.

Cold-Chain Handling For Pharmacies

Is cabergoline a cold-chain medication?

Cabergoline is not a cold-chain product but should be stored at controlled ambient temperatures according to the sponsor instructions.

Pharmacies should keep the original packaging and follow Good Distribution Practice for ambient products.

• Keep original packaging for expiry and stability information.
• Advise patients on avoiding heat and moisture when storing at home.
• Note any special transport instructions at dispensing for rural orders.

Guidelines For Proper Use (Pharmacist Counselling & Patient Checklist)

Australian Pharmacist Counselling Style

What should a pharmacist explain at dispensing?

Explain the weekly dosing schedule clearly and show how to record doses on a dosing calendar.

Discuss signs of hypotension, dizziness and psychiatric effects and what to do if they occur.

Emphasise the importance of notifying the prescriber if pregnancy is planned or suspected.

Document counselling in the patient record and provide written or electronic information where possible.

Patient Advice From PBS And National Health Authorities

Give patients a simple checklist they can take home or receive by email.

Include starting dose and schedule, key side effects to watch for and contact numbers for GP, endocrinologist and local pharmacist.

Include storage instructions and timing for monitoring tests such as baseline and periodic prolactin checks.

Advise when a cardiac review is indicated and provide links or references to TGA and PBS resources if available.

• Provide a downloadable factsheet and a monitoring checklist for prolactin testing.
• Offer follow-up phone or in-person review after the first dose and after dose changes.

Delivery Across Australia